2022 Vascular Discovery: From Genes to Medicine

摘要 动脉炎、血栓形成和血管生物学委员会（ATVB）和外周血管委员会 美国心脏病协会（AHA）每年春季召开“血管发现： 从基因到医学”最近的一次（面对面）于2019年5月5日至7日在伊利诺伊州芝加哥举行。的 会议取得圆满成功，有885人登记。560份摘要提交给 ATVB 2019，远高于往年提交的典型的约400篇摘要。这些 令人鼓舞的统计数字提供了切实证据，表明科学界的广泛兴趣和承诺。 社区在ATVB，PVD和血管医学的主题领域，以及对 会议的形式和气氛。基础科学家，转化研究人员和临床医生，经验丰富的 研究人员和早期的职业科学家，喜欢来参加这个AHA春季会议。下一个ATVB/PVD 会议定于2022年5月20日至22日在路易斯安那州新奥尔良的希尔顿酒店举行。如同 之前的申请，本提案特别要求支持我们的青年研究者旅行奖。 知道早期研究人员是我们科学进步的未来，我们的一个主要重点是 每年举行一次会议，目的是鼓励年轻的研究人员积极参与ATVB的工作 和AHA的PVD理事会。青年研究者旅行奖得到了NIH/NHLBI的支持， 15年这些奖项是我们招募、留住和积极吸引年轻人的战略的组成部分。 动脉硬化、血栓形成、血管生物学和血管医学研究领域的研究人员 这对NIH-NHLBI和美国人口的健康至关重要。

ABSTRACT The Councils on Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) and Peripheral Vascular Disease (PVD) of the American Heart Association (AHA) hold an annual Spring Meeting “Vascular Discovery: From Genes to Medicine” the most recent of which (in-person) was held in Chicago, IL, May 5-7, 2019. The meeting was a resounding success with 885 registrants. Five hundred and sixty abstracts were submitted to ATVB 2019, well above the typical ~400 abstracts that had been submitted in earlier years. These encouraging statistics provide tangible evidence of the broad interest and commitment of the scientific community in the topic areas of ATVB, PVD and vascular medicine and the overwhelming enthusiasm for the format and atmosphere of this meeting. Basic scientists, translational researchers and clinicians, seasoned investigators and early career scientists, enjoy coming to this AHA Spring meeting. The next ATVB/PVD conference is scheduled to be held May 20-22, 2022 at the Hilton in New Orleans, Louisiana. As with previous applications, this proposal specifically requests support for our Young Investigator Travel Awards. Knowing that early stage investigators are the future of our scientific progress, a major emphasis of our annual conference is to encourage the active involvement of the younger cohort of investigators in the ATVB and PVD Councils of the AHA. Young Investigator Travel Awards have been supported by the NIH/NHLBI for 15 years. These awards are an integral part of our strategy to recruit, retain and actively engage young investigators in the fields of arteriosclerosis, thrombosis, vascular biology and vascular medicine research that are of major importance to the NIH-NHLBI and the health of the U.S. population.